Application no. and date | 09836751.9 (espacenet) (Federated) (European Patent Register), 20091209 | Patent/reg. no. and date | DK/EP 2370099, 20160420 | Publication date | 20111005 | Priority no. and date | US 121126 P, 20081209, US 169077 P, 20090414, US 224787 P, 20090710 | EP pub. no. and date |
EP 2370099 20111005 | Effective date | | Applicant/owner | Novavax, Inc., 9920 Belward Campus Drive
Rockville, MD 20850, US | Applicant ref. no. | P81602744DK00E | Inventor | PUSHKO, Peter, c/o NOVAVAX INC. 9920 Belward Campus Drive
Rockville, Maryland 20850, US, WU, Yingyun, c/o NOVAVAX INC. 9920 Belward Campus Drive
Rockville, Maryland 20850, US, MASSARE, Michael, c/o NOVAVAX INC. 9920 Belward Campus Drive
Rockville, Maryland 20850, US, LIU, Ye, c/o NOVAVAX INC. 9920 Belward Campus Drive
Rockville, Maryland 20850, US, SMITH, Gale, c/o NOVAVAX INC. 9920 Belward Campus Drive
Rockville, Maryland 20850, US, ZHOU, Bin, c/o NOVAVAX INC. 9920 Belward Campus Drive
Rockville, Maryland 20850, US | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | Opponent | | IPC Class | A61K 39/155 (2006.01) | Title | MODIFICEREDE RSV F-PROTEINER OG FREMGANGSMÅDER TIL DERES ANVENDELSE | Int. application no. | US2009067269 | Int. publication no. | WO2010077717 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|